The results indicated that patients with higher mRNA level of VEGFA had shorter overall survival (OS) (HR=2.45, 95% CI: 1.91-3.14, P<0.0001) (Figure 6A) and progression-free survival (PFS) (HR=2.4, 95% CI: 1.73-3.33, P<0.0001) (Figure 6B), which represent poor survival in ADC individuals, whilst high VEGFA expression could not serve as a predictor for OS (HR=1.05, 95% CI: 0.83-1.33, P=0.69) (Figure 6D) and PFS (HR=1.16, 95% CI: 0.7-1.94, P=0.57) (Figure 6E) in SQC patients. This evidence concerns the gene VEGFA and AIDS dementia complex.